Page 380«..1020..379380381382..390400..»

Punjab has highest no. of patients with high blood pressure, lowest follow-up rate: ICMR study – The Indian Express

Posted: Published on February 9th, 2021

India Hypertension Control Initiative (IHCI), a multi-partner initiative led by the Indian Council of Research (ICMR) has been successful in improving blood pressure control rates across four states. Continue reading

Posted in Hypertension | Comments Off on Punjab has highest no. of patients with high blood pressure, lowest follow-up rate: ICMR study – The Indian Express

Risk of hypertensive disorders of pregnancy linked to trophectoderm biopsy in new study – ESHRE

Posted: Published on February 9th, 2021

Risk of hypertensive disorders of pregnancy linked to trophectoderm biopsy in new study A large single-centre study has found a two-fold higher risk of pregnancy-related hypertension following blastocyst biopsy and frozen transfer than in non-biopsied controls. Continue reading

Posted in Hypertension | Comments Off on Risk of hypertensive disorders of pregnancy linked to trophectoderm biopsy in new study – ESHRE

[Full text] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Rec | NDT – Dove Medical Press

Posted: Published on February 9th, 2021

Introduction Hypertension intracerebral hemorrhage (ICH) is associated with high mortality and disability.14 Few effective treatments are available in the several prospective, randomized, controlled, multicenter trials, except for rapid blood-pressure lowering.58 Primary brain injury is mainly caused by mechanical damage to the surrounding tissues inducing by dissection and compression of the hematoma formation within the first few hours after ICH onset.9 Secondary brain injury caused by the physiologic response to the primary brain injury could lead more serious and fatal injury, which plays a key role in the overall prognosis of ICH.9 The preclinical studies have suggested that inhibition of neuroinflammation holds beneficial effect on ICH animals after central nervous system (CNS) injury.2,913 The renin-angiotensin-aldosterone system (RAAS), existing in the cardiovascular system, kidneys and CNS, can influence the outcome of ischemic stroke.1416 Angiotensin (Ang) is a product of the proteolytic cleavage of Ang I by Angiotensin-converting enzyme (ACE) and is the pivotal protein of the RAAS for the regulation of blood pressure.14 Ang can also produce an inflammatory response by binding to type-1 Ang receptors.17 Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are two critical suppressors of the RAAS and widely used as the first-line anti-hypertensive drugs.18 Previous researches have shown that ACEIs/ARBs have multiple neuroprotective effects, such as slowing inflammatory processes, inhibition of fibrinoid necrosis, anti-apoptotic and anti-oxidant effects by the reduction of Ang in the animal models after CNS injury.2,17,1924 However, the role of ACEIs and ARBs in ICH patients with hypertension remains elusive in clinic.25 Herein, the aim of the present study is to evaluate the effect of ACEIs/ARBs on ICH patients with hypertension using a retrospective, single-center data analysis. This retrospective study was approved by the Ethics Committee of the Southwest Hospital, Third Military Medical University (approval no. Continue reading

Posted in Hypertension | Comments Off on [Full text] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Rec | NDT – Dove Medical Press

REVEAL Lite 2 Risk Calculator Offers Simplified Model to Assess One-Year Mortality Risk Status in Patients with Pulmonary Arterial Hypertension (PAH)…

Posted: Published on February 9th, 2021

SOUTH SAN FRANCISCO, Feb. 3, 2021 /PRNewswire/ --The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from an analysis determining the validity of the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) Lite 2 risk calculator, an abridged version of the REVEAL 2.0 risk calculator, in patients with pulmonary arterial hypertension (PAH), a rapidly progressive disease with no known cure.1,2,3 The analysis showed that REVEAL Lite 2 offers a simplified method of risk assessment using six non-invasive and modifiable variables that may be implemented routinely in daily clinical practiceand can be used in conjunction with REVEAL 2.0, and differentiates patients among low, intermediate and high risk of one-year mortality Continue reading

Posted in Hypertension | Comments Off on REVEAL Lite 2 Risk Calculator Offers Simplified Model to Assess One-Year Mortality Risk Status in Patients with Pulmonary Arterial Hypertension (PAH)…

Indy doctor helping to bring first-of-its-kind treatment for lung disease that could help COVID-19 patients – WISHTV.com

Posted: Published on February 9th, 2021

INDIANAPOLIS (WISH) Dr. Ashwin Ravichandran at Ascension St. Vincent Hospital in Indianapolis wasnt predicting the future when he first joined a clinical trial for a new way to treat pulmonary hypertension, a type of blood pressure in the lungs now associated with COVID-19 Continue reading

Posted in Hypertension | Comments Off on Indy doctor helping to bring first-of-its-kind treatment for lung disease that could help COVID-19 patients – WISHTV.com

Vitamin D and hypertensive disorders of pregnancy – Contemporary Obgyn

Posted: Published on February 9th, 2021

For more information, visitSMFM.org A prospective study has found that even though vitamin D prophylaxis fails to prevent hypertensive disorders of pregnancy, it does increase maternal and cord blood vitamin D levels. Study results were presented virtually at the 41st Annual Pregnancy meeting of the Society for Maternal Fetal Medicine (SMFM). Continue reading

Posted in Hypertension | Comments Off on Vitamin D and hypertensive disorders of pregnancy – Contemporary Obgyn

Ocular Hypertension Treatment Market Detailed Analysis Of Current Industry Figures With Forecasts Growth By 2027 KSU | The Sentinel Newspaper – KSU |…

Posted: Published on February 9th, 2021

TheOcular Hypertension Treatment Marketresearch report thoroughly explains each and every aspect related to the Global Ocular Hypertension Treatment Market, which facilitates the reports reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. Ocular Hypertension Treatment Market Insight: Ocular hypertension treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period Continue reading

Posted in Hypertension | Comments Off on Ocular Hypertension Treatment Market Detailed Analysis Of Current Industry Figures With Forecasts Growth By 2027 KSU | The Sentinel Newspaper – KSU |…

Study Reports Outcomes of HBV- and HCV-Infected Pregnant Women – MD Magazine

Posted: Published on February 9th, 2021

Findings from a new study reported that hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in pregnant women was associated with higher incidences of premature births. HCV infection was further linked to edemas, hypertension, and pruritus. Investigators from the Department of Infectious Disease and Hepatology, Medical University of Bialystok, Poland, evaluated the course of pregnancy among women infected with either viruses Continue reading

Posted in Hypertension | Comments Off on Study Reports Outcomes of HBV- and HCV-Infected Pregnant Women – MD Magazine

Lineage Enters Into Exclusive Agreement with Neurgain Technologies to Evaluate Novel Delivery System for OPC1 to Treat Spinal Cord Injury – BioSpace

Posted: Published on February 9th, 2021

Feb. 8, 2021 13:00 UTC CARLSBAD, Calif.--(BUSINESS WIRE)-- Lineage Cell Therapeutics, Inc.(NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it has entered into an exclusive option and license agreement with Neurgain Technologies, Inc. (Neurgain), a medical device company that is commercializing technology developed by neurosurgeons at the University of California San Diego (UC San Diego) Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Lineage Enters Into Exclusive Agreement with Neurgain Technologies to Evaluate Novel Delivery System for OPC1 to Treat Spinal Cord Injury – BioSpace

New Findings Offer Hope for Recovery From Paralysis From Spinal Cord Injuries – The Swaddle

Posted: Published on February 9th, 2021

Spinal cord injuries (SCIs) are partial or complete damages to the spinal cord, typically resulting in permanent disability and paralysis, with devastating effects on the survivors lives, families, and society. In India alone, there are 15,000 new cases of SCIs annually, resulting in a staggering 1.5 million number of SCI survivors in India. SCIs typically result in permanent disability, and often paralysis. Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on New Findings Offer Hope for Recovery From Paralysis From Spinal Cord Injuries – The Swaddle

Page 380«..1020..379380381382..390400..»